Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 304-310

  Cifarelli, Alberta ^a   Musto, Carmine ^a   Parma, Antonio ^a   Pandolfi, Claudia ^a   Pucci, Edoardo ^a   Fiorilli, Rosario ^a   De Felice, Francesco ^a   Nazzaro, Marco Stefano ^a   Violini, Roberto ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Congenital heart disease in adults; Intracardiac Echo; Patent Foramen Ovale

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM SEPTUM ANEURYSM; HEART RIGHT LEFT SHUNT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TRANSCATHETER PATENT FORAMEN OVALE CLOSURE; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952741479     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.051     Document Type: Article

References (27)

1. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
2. Mas J.L., Arquizan C., Lamy C., et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345 (2001) 1740-1746
3. Martín F., Sánchez P.L., Doherty E., et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 106 (2002) 1121-1126
4. Braun M.U., Fassbender D., Schoen S.P., et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 39 (2002) 2019-2025
5. Windecker S., Wahl A., Nedeltchev K., et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in oatients with cryptogenic stroke. J Am Coll Cardiol 44 (2004) 750-758
6. Giardini A., Donti A., Formigari R., et al. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 67 (2006) 625-629
7. Spies C., Strasheim R., Timmermanns I., and Schraeder R. Patent foramen ovale closure with cryptogenetic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J 27 (2006) 365-371
8. Harms V., Reisman M., Fuller C.J., et al. Outcome after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol 99 (2007) 1312-1315
9. Slavin L., Tobis J.M., Rangarajan K., et al. 5 years experience with percutaneous closure of patent foramen ovale. Am J Cardiol 99 (2007) 1316-1320
10. Spies C., Timmermanns I., Reissmann U., van Essen J., and Schräder R. Patent foramen ovale closure with the Intrasept occluder: complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Catheter Cardiovasc Interv. 71 3 (2008 Feb 15) 390-395
11. Hanley P.C., Tajik A.J., Hynes J.K., et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: a report of 80 consecutive cases. J Am Coll Cardiol 6 (1985) 1370-1382
12. Sharafuddin M.J., Gu X., Titus J.L., Urness M., Cervera-Ceballos J.J., and Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 95 (1997) 2162-2168
13. Donti A., Giardini A., Salomone L., Formigari R., and Picchio F.M. Transcatheter patent foramen ovale closure using the premere PFO occlusion system. Catheter Cardiovasc Interv 68 (2006) 736-740
14. Bogousslavsky J., Garazi S., Jeanrenaud X., Aebischer N., and Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Lausanne stroke with paradoxical embolism study group. Neurology 46 (1996) 1301-1305
15. Homma S., Sacco R.L., Di Tullio M.R., Sciacca R.R., Mohr J.P., and PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105 (2002) 2625-2631
16. Mohr J.P., Thompson J.L., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
17. Homma S., Di Tullio M.R., Sacco R.L., Sciacca R.R., Smith C., and Mohr J.P. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 28 (1997) 2376-2381
18. Devuyst G., Bogousslavsky J., Ruchat P., et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous trans-oesophageal and trans-cranial Doppler ultrasound. Neurology 47 (1996) 1162-1166
19. Khairy P., O C.P., Donnell, and Landzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139 (2003) 753-760
20. Wahl A., Krumsdorf U., Meier B., et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 45 (2005) 377-380
21. Krumsdorf U., Ostermayer S., Billinger K., et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale in 1000 consecutive patients. J Am Coll Cardiol 43 (2004) 302-309
22. Anzai H., Child J., Natterson B., et al. Incidence of thrombus formation on the CardioSEAL device and the Amplatzer interatrial closure devices. Am J Cardiol 93 (2004) 426-431
23. Schwerzmann M., Windecker S., Wahl A., et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 90 2 (2004) 186-190
24. Fischer D., Fuchs M., Schaefer A., et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex((R)) occluder device with conjunctive intensified anticoagulation regimen. J Interv Cardiol 21 2 (Apr 2008) 183-189
25. von Bardeleben R.S., Richter C., Otto J., et al. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: difference in occlusion systems and influence of atrial septum aneurysm. Int J Cardiol 134 (2009) 33-41
26. Bartel T., Konorza T., Arjumand J., et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 107 (2003) 795-797
27. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150